PBS change opens door to dual therapy for more patients with PAH

A change that allows physicians to prescribe dual therapy for patients with pulmonary arterial hypertensions (PAH) on the PBS has been “a long time coming”, says respiratory physician Associate Professor Edmund Lau. From 1 October, patients with WHO Functional Class III and IV PAH can receive subsidised therapy with both an endothelin receptor antagonist (ERA) ...

Already a member?

Login to keep reading.

© 2021 the limbic